Biologics Are The Fastest Growing Segment Fueling The Growth Of Biologics Market


https://www.coherentmarketinsights.com/market-insight/biologics-market-2663
Biologics Market


Market Overview:

Biologics are medicinal products manufactured in biological systems. They help treat various complex diseases like cancer, chronic diseases, and autoimmune disorders. They exploit biological pathways within cells to fight diseases.

Market key trends:
The rising prevalence of chronic diseases is one of the key trends contributing to the growth of the biologics market. Chronic diseases like cancer, diabetes, and cardiovascular diseases are increasing globally. As per the World Health Organization (WHO), chronic diseases accounted for approximately 60% of global deaths in 2001. Biologics provide effective treatment solutions for chronic diseases.
Segment Analysis
The biologics market is segmented based on product type into monoclonal antibodies, vaccines, recombinant hormones/proteins, gene therapy, and cell therapies. Among these, the monoclonal antibodies segment dominated the market in 2023 and is expected to continue its dominance during the forecast period. Monoclonal antibodies have specific mechanisms of action and are highly effective in targeting chronic and life-threatening diseases. In addition, the wide acceptance of monoclonal antibodies for the treatment of various cancers and autoimmune disorders is driving the growth of this segment.

The global Biologics Market Demand is estimated to be valued at US$ 401.96 Bn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.



Key Takeaways
The global biologics market is expected to witness high growth, exhibiting a CAGR of 9.3% over the forecast period, due to increasing prevalence of chronic diseases and growing demand for antibody therapies and targeted drugs for treating cancer and other life-threatening conditions.

Regional analysis: North America dominated the global biologics market in 2023 and is expected to continue its dominance during the forecast period. This is attributed to the highly developed healthcare sector, rising biologics R&D spending, and increasing adoption of biologics in the US for treating various chronic diseases. Asia Pacific is anticipated to exhibit the highest CAGR during the forecast period, owing to rapidly developing biologics production capabilities and increasing investments by key players in countries including China and India.

Key players: Key players operating in the biologics market are Novartis AG., AstraZeneca PLC., Bayer AG, Sanofi SA., Pfizer Inc., Merck & Co., Johnson and Johnson, GlaxoSmithKline PLC., Amgen Inc., AbbVie Inc., F. Hoffmann-La Roche AG., Eli Lilly and Company., and AGC Biologics. These players are focusing on new product developments and acquisitions to strengthen their market position. For instance, in 2022, Novartis acquired Xeva Biologics GmbH to strengthen its biosimilars pipeline.



Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more